Neogenomics Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Neogenomics Inc 公司

NeoGenomics, Inc. 提供一系列腫瘤診斷測試和諮詢服務，包括技術實驗室服務。該公司由專門從事病理學和腫瘤學的執業醫師提供對實驗室測試結果的專業解釋。其部門包括臨牀服務和高級診斷。臨牀服務部門包括臨牀癌症檢測；解釋和諮詢服務；分子和 NGS 檢測，以及全面的技術和專業服務。其臨牀服務客戶包括社區病理學和腫瘤學診所、醫院病理學實驗室、參考實驗室和學術中心。高級診斷部門包括臨牀試驗和研究、驗證實驗室服務和信息學。其高級診斷客戶包括製藥公司，該公司爲其提供測試和其他服務以支持其研究和臨牀試驗。

Neogenomics Inc簡介



公司代碼NEO

公司名稱Neogenomics Inc

上市日期Dec 10, 2012

CEOMr. Antony P. Zook

員工數量2200

證券類型Ordinary Share

年結日Dec 10

公司地址9490 Neogenomics Way

城市FORT MYERS

上市交易所NASDAQ Capital Market Consolidated

國家United States of America

郵編33912

電話12397680600

網址https://neogenomics.com/

公司代碼NEO

上市日期Dec 10, 2012

CEOMr. Antony P. Zook

Neogenomics Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

186.66K

+12.00%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

--

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

--

Dr. Alison L. Hannah, M.D.

Independent Director

--

Mr. Gregory Aunan

Chief Accounting Officer

--

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

--

Mr. Michael A. Kelly

Lead Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

186.66K

+12.00%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

--

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

--

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

暫無數據

業務

地區

業務USD

名稱

營收

佔比

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

股東統計

更新時間: 10月31日週五

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.73%

The Vanguard Group, Inc.

10.72%

Greenhouse Funds LLLP

5.74%

First Light Asset Management, LLC

5.29%

State Street Investment Management (US)

3.95%

其他

60.56%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.73%

The Vanguard Group, Inc.

10.72%

Greenhouse Funds LLLP

5.74%

First Light Asset Management, LLC

5.29%

State Street Investment Management (US)

3.95%

其他

60.56%

股東類型

持股股東

佔比

Investment Advisor

49.75%

Investment Advisor/Hedge Fund

30.92%

Hedge Fund

13.93%

Research Firm

2.37%

Individual Investor

1.29%

Pension Fund

1.20%

Bank and Trust

0.59%

Sovereign Wealth Fund

0.09%

Family Office

0.05%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

568

127.88M

98.83%

-9.78M

2025Q2

571

126.82M

98.17%

-12.95M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

17.77M

13.76%

-516.86K

-2.83%

Jun 30, 2025

The Vanguard Group, Inc.

14.10M

10.92%

-126.36K

-0.89%

Jun 30, 2025

Greenhouse Funds LLLP

7.43M

5.75%

+2.72M

+57.83%

Jun 30, 2025

First Light Asset Management, LLC

6.85M

5.3%

+803.61K

+13.30%

Jun 30, 2025

State Street Investment Management (US)

5.11M

3.96%

+21.77K

+0.43%

Jun 30, 2025

Macquarie Investment Management

4.81M

3.72%

+130.73K

+2.80%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

4.29M

3.32%

+448.53K

+11.66%

Jun 30, 2025

Schroder Investment Management North America Inc.

3.72M

2.88%

-587.33K

-13.63%

Jun 30, 2025

American Century Investment Management, Inc.

3.52M

2.72%

+197.88K

+5.96%

Jun 30, 2025

Millennium Management LLC

3.32M

2.57%

-3.40M

-50.63%

Jun 30, 2025

持股ETF



更新時間: 11月6日週四

機構名稱

佔比

SPDR S&P Health Care Services ETF

1.75%

Invesco S&P SmallCap Health Care ETF

0.63%

WisdomTree BioRevolution Fund

0.58%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.4%

Inspire Small/Mid Cap ESG ETF

0.2%

iShares U.S. Healthcare Providers ETF

0.16%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

0.09%

Nuveen ESG Small-Cap ETF

0.09%

iShares ESG Select Screened S&P Small-Cap ETF

0.08%

SPDR S&P 600 Small Cap Value ETF

0.08%

SPDR S&P Health Care Services ETF

佔比1.75%

Invesco S&P SmallCap Health Care ETF

佔比0.63%

WisdomTree BioRevolution Fund

佔比0.58%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.4%

Inspire Small/Mid Cap ESG ETF

佔比0.2%

iShares U.S. Healthcare Providers ETF

佔比0.16%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

佔比0.09%

Nuveen ESG Small-Cap ETF

佔比0.09%

iShares ESG Select Screened S&P Small-Cap ETF

佔比0.08%

SPDR S&P 600 Small Cap Value ETF

佔比0.08%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據